Perthera, the market leader in Precision Oncology technology, utilizes Therapeutic Intelligence, combined with a Molecular Tumor Board and AI, to advance patient outcomes. The Perthera Platform generates treatment recommendations precisely matched to patients using their medical, treatment and molecular information. Perthera has proven results demonstrating increased Overall and Progression-Free Survival rates in patients using ranked therapeutic options. The Perthera Precision Oncology Platform has been utilized at over 250 cancer centers and by more than 10% of oncologists across the US.